Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BDNF | P23560 | 3/20 | 0.49 |
| ▸ | MDK | P21741 | 3/20 | 0.49 |
| ▸ | PTN | P21246 | 2/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | CXCL12 | P48061 | 2/20 | 0.42 |
| ▸ | CXCL10 | P02778 | 1/20 | 0.42 |
| ▸ | CXCL8 | P10145 | 1/20 | 0.42 |
| ▸ | CCL2 | P13500 | 1/20 | 0.42 |
| ▸ | CCL5 | P13501 | 1/20 | 0.42 |
| ▸ | F10 | P00742 | 2/20 | 0.41 |
| ▸ | LGALS3 | P17931 | 3/20 | 0.40 |
| ▸ | BMP2 | P12643 | 2/20 | 0.38 |
| ▸ | VEGFA | P15692 | 2/20 | 0.38 |
| ▸ | SHH | Q15465 | 1/20 | 0.38 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.38 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.38 |
| ▸ | CD69 | Q07108 | 1/20 | 0.37 |
| ▸ | CHIA | Q9BZP6 | 1/20 | 0.36 |
| ▸ | FGF2 | P09038 | 3/20 | 0.36 |
| ▸ | IFNG | P01579 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29523446 | 1.00 | BDNF (0.49) | BDNFMDKPTNMAPK1CXCL12 | |
| SCHEMBL5790851 | 0.94 | MDK (0.53) | BDNFMDKPTNMAPK1CXCL12 | |
| SCHEMBL29535260 | 0.94 | MDK (0.53) | BDNFMDKPTNMAPK1CXCL12 | |
| SCHEMBL29531877 | 0.94 | MDK (0.53) | BDNFMDKPTNMAPK1CXCL12 | |
| SCHEMBL18079769 | 0.94 | MDK (0.53) | BDNFMDKPTNMAPK1CXCL12 | |
| SCHEMBL13321878 | 0.91 | MDK (0.61) | BDNFMDKPTNMAPK1CXCL12 | |
| SCHEMBL29371806 | 0.91 | MDK (0.61) | BDNFMDKPTNMAPK1CXCL12 | |
| SCHEMBL27448112 | 0.90 | BDNF (0.60) | BDNFMDKPTNMAPK1CXCL12 | |
| SCHEMBL29908269 | 0.86 | MDK (0.54) | BDNFMDKPTNMAPK1F10 | |
| SCHEMBL23336378 | 0.85 | MDK (0.53) | BDNFMDKPTNMAPK1CXCL12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12624128-B2 | Low molecular weight chondroitin sulfate, composition, preparation method and use thereof | Nanjing Hanxin Pharmaceutical Technology Co., Ltd. (CN) | 2026-05-12 | — | — | US | claimed |
| CN-119708287-A | Compound for treating myocardial infarction | 复旦大学 | 2025-03-28 | — | — | CN | claimed |
| CN-119685297-A | Chondroitin sulfate degrading enzyme and application thereof | 巨微(无锡)生物技术有限公司 | 2025-03-25 | — | — | CN | claimed |
| CN-114846147-B | Low molecular weight chondroitin sulfate, composition comprising same, preparation method thereof and application thereof | 南京汉欣医药科技有限公司 | 2024-07-02 | — | — | CN | claimed |
| CN-118240788-A | Chondroitin sulfate synthase with improved enzyme activity, mutant coding gene and application thereof | 山东鑫晟生物技术股份有限公司 | 2024-06-25 | — | — | CN | claimed |
| US-20230250199-A1 | LOW MOLECULAR WEIGHT CHONDROITIN SULFATE, COMPOSITION, PREPARATION METHOD AND USE THEREOF | Nanjing Hanxin Pharmaceutical Technology Co., Ltd. (CN) | 2023-08-10 | — | — | US | claimed |
| CN-116392504-A | Application of marine organism-derived natural sulfated polysaccharide as anti-coronavirus and disease-causing drug | 中国海洋大学 | 2023-07-07 | — | — | CN | claimed |
| CN-113637599-B | Food-grade safe saccharomycete for producing chondroitin sulfate lyase ABCI and application thereof | 江南大学 | 2023-04-28 | — | — | CN | claimed |
| US-11572421-B2 | Low molecular weight chondroitin sulfate, composition, preparation method and use thereof | Nanjing Hanxin Pharmaceutical Technology Co., Ltd. (CN) | 2023-02-07 | — | — | US | claimed |
| EP-4053290-A1 | LOW MOLECULAR WEIGHT CHONDROITIN SULFATE, COMPOSITION CONTAINING SAME, AND PREPARATION METHOD THEREFOR AND USE THEREOF | Nanjing Letop Biotechnology Co., Ltd. (CN) | 2022-09-07 | — | — | EP | claimed |
| CN-114853920-A | Giant salamander cartilage chondroitin sulfate and extraction method thereof | 清华大学 | 2022-08-05 | — | — | CN | claimed |
| CN-114846147-A | Low molecular weight chondroitin sulfate, compositions comprising the same, methods of making the same, and uses thereof | 南京乐韬生物科技有限公司 | 2022-08-02 | — | — | CN | claimed |
| CN-114601848-A | Application of chondroitin sulfate as medicine for resisting coronavirus and treating diseases caused thereby | 南开大学 | 2022-06-10 | — | — | CN | claimed |
| US-12624128-B2 | Low molecular weight chondroitin sulfate, composition, preparation method and use thereof | Nanjing Hanxin Pharmaceutical Technology Co., Ltd. (CN) | 2026-05-12 | — | — | US | disclosed |
| US-12624128-B2 | Low molecular weight chondroitin sulfate, composition, preparation method and use thereof | Nanjing Hanxin Pharmaceutical Technology Co., Ltd. (CN) | 2026-05-12 | — | — | US | disclosed |
| CN-121852488-A | Method for producing N-acetylgalactosamine sulfate by two-step enzyme catalyzed chondroitin sulfate degradation | 江南大学 | 2026-04-14 | — | — | CN | disclosed |
| CN-114846147-A | Low molecular weight chondroitin sulfate, compositions comprising the same, methods of making the same, and uses thereof | 南京乐韬生物科技有限公司 | 2022-08-02 | — | — | CN | disclosed |
| CN-112251426-B | Chondroitin sulfate lyase, and coding gene and application thereof | 山东大学 | 2022-07-26 | — | — | CN | disclosed |
| CN-114601848-A | Application of chondroitin sulfate as medicine for resisting coronavirus and treating diseases caused thereby | 南开大学 | 2022-06-10 | — | — | CN | disclosed |
| CN-114317640-A | Method for preparing chondroitin sulfate with different molecular weights based on PAPS | 江南大学 | 2022-04-12 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230250199-A1 | LOW MOLECULAR WEIGHT CHONDROITIN SULFATE, COMPOSITION, PREPARATION METHOD AND USE THEREOF | CD44, CSGALNACT1, COL2A1 | BDNF 595/4885MDK 962/4885PTN 1083/4885 |
| US-11572421-B2 | Low molecular weight chondroitin sulfate, composition, preparation method and use thereof | CD44, CSGALNACT1, COL2A1 | BDNF 595/4885MDK 962/4885PTN 1083/4885 |
| US-12624128-B2 | Low molecular weight chondroitin sulfate, composition, preparation method and use thereof | COL2A1, CD44, COL1A1 | BDNF 1125/4885MDK 2180/4885PTN 1876/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.